Related Experiment Video
Updated: Mar 3, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137
Zong Wang1, Jiangwei Yuan2, Li Li1
1Department of Neurosurgery, Zhumadian Central HospitalZhumadian 463000, P. R. China.
Abstract:
Long non-coding RNA (lncRNA) X inactivate-specific transcript (XIST) acts as an important regulator in tumor progression. However, its expression and the underlying mechanism in glioma remain unclear. The aim of this study was to explore the potential function of XIST in glioma progression. In the present study, our data showed that the expression of XIST was significantly up-regulated in glioma tissues and enhanced the proliferation of glioma cells. The expression of miR-137 was significantly decreased in glioma tissues. Further correlation analysis demonstrated that there was a negative correlation between XIST expression and miR-137 expression. Bioinformatics prediction and luciferase reporter assays demonstrated that miR-137 could directly bind to XIST and negatively regulated the expression of miR-137. Additionally, our data further showed that XIST could up-regulate the expression of miR-137 targeted gene Rac1 through acting as an endogenous sponge of miR-137. In addition, we found that Rac1 inhibition or miR-137 overexpression could suppress glioma cells proliferation induced by XIST overexpression. Thus, a novel XIST-miR-137-Rac1 pathway regulatory axis in glioma pathogenesis was revealed in the present study. Overall, our study indicated that XIST could be a potential therapeutic target in the treatment of glioma.
Insights
Long non-coding RNA XIST is upregulated in glioma, promoting cell proliferation. It sponges miR-137, leading to increased Rac1 expression, suggesting XIST as a therapeutic target for glioma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA XIST (X-inactive specific transcript) is implicated in tumor progression.
- The role and regulatory mechanisms of XIST in glioma remain largely uncharacterized.
Purpose of the Study:
- To investigate the expression and function of XIST in glioma.
- To elucidate the molecular mechanism underlying XIST's role in glioma pathogenesis.
Main Methods:
- Analysis of XIST and miR-137 expression in glioma tissues.
- Cell proliferation assays.
- Bioinformatics prediction and luciferase reporter assays to confirm direct binding.
- Western blotting to assess protein expression.
Main Results:
- XIST expression was significantly upregulated in glioma tissues and promoted glioma cell proliferation.
- miR-137 expression was significantly decreased in glioma tissues.
- XIST directly bound to and negatively regulated miR-137, acting as an endogenous sponge.
- XIST upregulated Rac1 expression by sponging miR-137.
- Rac1 inhibition or miR-137 overexpression suppressed XIST-induced glioma cell proliferation.
Conclusions:
- A novel regulatory axis involving XIST, miR-137, and Rac1 in glioma pathogenesis was identified.
- XIST acts as an oncogenic lncRNA in glioma by modulating the miR-137-Rac1 pathway.
- XIST represents a potential therapeutic target for glioma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Inheritance of Chromatin Structures
MicroRNAs
MicroRNAs
Experimental RNAi
